https://www.prnewswire.com/news-releases/european-medicines-agency-grants-orphan-designation-to-can-fites-cf102-in-the-treatment-of-liver-cancer-300157647.html
European Medicines Agency Grants Orphan Designation to Can-Fite's CF102 in the Treatment of Liver...
/PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...